RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Samsara BioCapital, LLC's Holding History (CIK: 0001744967)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022

Shares 267,996 Value ($000) $2,181 Avg Close $6.69 Range $4.92 - $9.40

Q1 2022

Shares 539,236 Value ($000) $3,861 Avg Close $10.63 Range $5.80 - $18.23

Q4 2021

Shares 539,236 Value ($000) $9,237 Avg Close $18.82 Range $15.25 - $23.86

Q3 2021

Shares 752,939 Value ($000) $17,325 Avg Close $28.34 Range $17.80 - $42.81

Q2 2021

Shares 775,583 Value ($000) $28,309 Avg Close $29.60 Range $19.68 - $38.39

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2022	267,996	$2,181	$6.69	$4.92 - $9.40
Q1 2022	539,236	$3,861	$10.63	$5.80 - $18.23
Q4 2021	539,236	$9,237	$18.82	$15.25 - $23.86
Q3 2021	752,939	$17,325	$28.34	$17.80 - $42.81
Q2 2021	775,583	$28,309	$29.60	$19.68 - $38.39